AIL
IART icon

AGF Investments LLC’s Integra LifeSciences IART Stock Holding History

AGF Investments LLC’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,717
Closed -$464K – 649
2019
Q3 		$464K Buy
7,717
+1,331
+21% +$79.3K 0.11% 262
2019
Q2 		$357K Buy
6,386
+2,244
+54% +$116K 0.07% 189
2019
Q1 		$231K Buy
4,142
+1,287
+45% +$65.5K 0.05% 240
2018
Q4 		$129K Buy
2,855
+2,713
+1,911% +$149K 0.02% 370
2018
Q3 		$9K Sell
142
-142
-50% -$8.82K ﹤0.01% 683
2018
Q2 		$18 Buy
+284
New +$17.6K ﹤0.01% 656

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AGF Investments LLC's IART Position: Q4 2019 in Review

AGF Investments LLC sold out of Integra LifeSciences (IART) in Q4 2019, closing a stake of 7,717 shares — an estimated $464K sold.

AGF Investments LLC first reported a position in IART in Q2 2018 and held it in 6 quarters. The position peaked at $464K in Q3 2019. 279 funds tracked by Wall St. Rank hold IART as of Q4 2019.

  • AGF Investments LLC reported no remaining Integra LifeSciences position as of Q4 2019 after selling out during the quarter.
  • AGF Investments LLC sold 7,717 Integra LifeSciences shares in Q4 2019, an estimated $464K.
  • AGF Investments LLC first reported a position in Integra LifeSciences in Q2 2018 and held it in 6 quarters.
  • AGF Investments LLC's Integra LifeSciences position peaked at $464K in Q3 2019.
  • 279 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2019.

Based on AGF Investments LLC's 13F filing for Q4 2019, filed 12 Feb 2020.